Инновации и финансирование: как спасти отложенные кандидаты в лекарства

Newsletter | August 12, 2026 FEATURED ARTICLE A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D. This week on Business of Biotech, Annette Bakker and Andrew Lo examine how abandoned drug candidates can be transformed into viable therapies through innovation and finance. INDUSTRY INSIGHTS $1.5M Grant Expands Biotech Training Capacity At Johnston Community College A $1.5 million Golden LEAF grant will expand biotech training capacity, helping meet growing demand for GMP, aseptic processing, automation, robotics, and other skills tied to North Carolina’s workforce. Open-Source Technologies Within Clinical Data Science Accelerate innovation in clinical trials by embracing open-source technologies that enhance data analysis, improve scalability, and unlock advanced predictive and machine-learning capabilities. Harnessing Predictive Modeling To Overcome Trial Enrollment Challenges By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently. Leading Recruitment With A Strong Alzheimer's Referral Pool A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites. The Missing Piece In Clinical Trial Management: Ocular Endpoints Unveil how specialized endpoint execution closes critical gaps in ophthalmic trials, improving assessment consistency, protocol adherence, data quality, and participant retention. Subject Matter Experts Matter In Decision-Making Expert-led ontology and taxonomy practices help organize data into meaningful hierarchies, making it easier to connect diseases, drug targets, and strategic insights that support stronger decisions. The New Era Of Psychedelic Research: Progress And Promise Learn how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research. Accelerating Biologics With Seamless Technology Transfer Discover how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.